[肺癌患者血浆中血管性血友病因子抗原（VIIIR:Ag）、凝血因子Ⅷ促凝活性（VIII:C）及纤维蛋白原水平]
[Levels of VIIIR:Ag, VIII:C and fibrinogen in plasma of patients with lung cancer].
作者信息
Ding Y P, Feng B Y, Ma Z F
机构信息
Department of Respiratory Medicine, Worker's Hospital of Hainan Provice, Haikou.
出版信息
Zhonghua Jie He He Hu Xi Za Zhi. 1994 Oct;17(5):301-2, 319-20.
Levels of VIIIR: Ag, VIII: C and fibrinogen (Fbg) in plasma have been measured in 80 patients with primary lung cancer. The results demonstrate that the plasma levels of VIIIR: Ag, VIII:C and Fbg in patients with lung cancer increase significantly in comparison with normal control group (P < 0.001). The levels increase along with the disease progressing. After treatment, all the three levels have decreased in treatment effective group. It is concluded that the measurements of plasma levels of VIIIR: Ag, VIII:C and Fbg are important in judging the condition of patients, to prognose and instruct the treatment for patients with lung cancer.
对80例原发性肺癌患者的血浆血管性血友病因子相关抗原（VIIIR:Ag）、凝血因子Ⅷ促凝活性（VIII:C）和纤维蛋白原（Fbg）水平进行了检测。结果表明，肺癌患者血浆中VIIIR:Ag、VIII:C和Fbg水平与正常对照组相比显著升高（P<0.001）。这些水平随疾病进展而升高。治疗后，治疗有效组的这三项水平均有所下降。结论是，检测血浆中VIIIR:Ag、VIII:C和Fbg水平对判断肺癌患者病情、预后及指导治疗具有重要意义。
Zotero 插件